4th Quarter - Report

NVG, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual property and potential changes to the patent system, generally

LobbyistCovered position, as disclosed
ANDREA LARUE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

FDA - rare and orphan disease issues; H.R. 34, 21st Century CURES Act, provisions of Tsunami Warning, Education & Research Act of 2015; Prescription drug coverage and payment policies; Medical innovation issues; H.R. 1537, Advancing Hope Act of 2015; S. 1878, Advancing Hope Act of 2016

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
PATRICIA GRIFFIN —
ANDREA LARUE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1537 (114th), H.R. 34 (114th), S. 1878 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.